Ready to transform your molecule lifecycle decisions?
Join the next generation of data-driven pharmaceutical strategy. Deploy in 4-6 weeks.
Industry Intelligence
Decision Intelligence for the $971B Pharma Market
From patent cliff defense to ADC competitive positioning, we power intelligent decisions across every stage of the molecule lifecycle.
The Market Landscape
Critical demand signals driving the need for molecule lifecycle decision intelligence.
$0B+Revenue at Risk (2025-2030)
0+Companies Profiled
0%Cost Reduction vs. Traditional
0xFaster Feedback Cycles
Solutions
Engagement Categories
Eight critical market dynamics where Behavior Labs delivers immediate value across the molecule lifecycle.
Critical
Patent Cliff Defense
War-gaming simulations and franchise transition planning for companies facing $200B+ in combined LOE exposure between 2025-2030.
$108B+Revenue at risk
Critical
ADC Competitive Intelligence
Real-time competitive monitoring across 15+ Phase 3 ADC trials, biomarker stratification, and head-to-head positioning analytics.
$30B+Market by 2030
High
Obesity & GLP-1 Strategy
Market entry war-gaming, brand development, and competitive intelligence for the $100B+ obesity/metabolic market.
$100B+TAM by 2030
High
Next-Gen IO Combinations
Checkpoint inhibitor combination strategy, ADC-IO positioning, and biomarker-driven patient selection across solid tumors.
$253BCombined revenue pool
Critical
Precision Diagnostics
CDx lifecycle management, MRD monitoring strategy, and competitive intelligence across the rapidly evolving diagnostics ecosystem.
$12B+CDx market by 2030
High
Biosimilar Defense
Patient retention modeling, authorized generic strategy, and franchise defense planning for branded products facing biosimilar competition.
$322BRevenue pool at risk
Medium
Clinical Trial Innovation
External control arms, synthetic phenotype stratification, and 30-40% trial sample size reduction aligned with FDA ISTAND guidance.
30-40%Sample size reduction
Medium
Rare Disease & Gene Therapy
Small-N trial design optimization, gene therapy commercialization strategy, and phenotype-driven patient identification.
$40B+CGT market by 2030
Market Dynamics
The Patent Cliff Wave: 2025-2030
The largest wave of patent expirations in pharmaceutical history is creating acute demand for decision intelligence at every lifecycle stage.
2025Active
First Major Expirations
Entresto, Stelara, and early cardiovascular LOE events begin reshaping competitive dynamics across immunology and cardiology.
2026Imminent
Anticoagulant & Metabolic Cliff
Eliquis faces generic competition while early semaglutide patents begin to expire, impacting two of pharma's largest revenue pools.
2027Approaching
Oncology & Biologics Wave
Eylea, Entyvio, Cosentyx, and multiple oncology assets face biosimilar competition. ADC and bispecific antibody positioning intensifies.
2028Critical
The Keytruda Cliff
The single largest product LOE in pharmaceutical history: $29.5B+ in annual revenue faces patent expiration, reshaping the entire IO landscape.
2029-2030Structural
Portfolio-Wide Impact
Cumulative LOE exposure exceeds $200B across the top 50 pharma companies. Companies that invested in decision intelligence early will have decisive competitive advantages.
Differentiation
Why Behavior Labs
Agentic decision intelligence that combines the data breadth of IQVIA, the strategic framing of McKinsey, and the speed of AI platforms.
| Behavior Labs | Traditional Consulting | Legacy CI Platforms | Internal Teams | |
|---|---|---|---|---|
| Deployment Speed | 4-6 weeks | 3-6 months | 6-12 weeks | Ongoing |
| Cost vs. Consulting | 75% lower | Baseline | 50% lower | Headcount cost |
| Real-Time Intelligence | ||||
| War-Gaming Simulations | ||||
| Phenotype Stratification | ||||
| External Control Arms | ||||
| SOC2/HIPAA/ISO Compliant | Varies | |||
| Pay-Per-Molecule Pricing |
Behavior Labs
Deployment Speed
4-6 weeks
Cost vs. Consulting
75% lower
Real-Time Intelligence
War-Gaming Simulations
Phenotype Stratification
External Control Arms
SOC2/HIPAA/ISO Compliant
Pay-Per-Molecule Pricing
Traditional Consulting
Deployment Speed
3-6 months
Cost vs. Consulting
Baseline
Real-Time Intelligence
War-Gaming Simulations
Phenotype Stratification
External Control Arms
SOC2/HIPAA/ISO Compliant
Pay-Per-Molecule Pricing
Legacy CI Platforms
Deployment Speed
6-12 weeks
Cost vs. Consulting
50% lower
Real-Time Intelligence
War-Gaming Simulations
Phenotype Stratification
External Control Arms
SOC2/HIPAA/ISO Compliant
Pay-Per-Molecule Pricing
Internal Teams
Deployment Speed
Ongoing
Cost vs. Consulting
Headcount cost
Real-Time Intelligence
War-Gaming Simulations
Phenotype Stratification
External Control Arms
SOC2/HIPAA/ISO Compliant
Varies
Pay-Per-Molecule Pricing